• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Law on Amendments to the Law on Circulation of Medicines

PART ONE of TWO: With China and other European countries thriving, why is Russian pharma/biotech still invisible? A brief examination of why, and whether change is likely anytime soon.

Steve Walker    November 27, 2018 November 27, 2018    No Comments on PART ONE of TWO: With China and other European countries thriving, why is Russian pharma/biotech still invisible? A brief examination of why, and whether change is likely anytime soon.

Russia’s pharmaceutical market-2018 Is the Russian pharmaceutical market on course for rapid growth, or will it remain a moribund market plagued by stagnation, decay and persistent drug shortages? The Russian… Read more »

Investment, Pharmaceuticals    Adam Muspratt, Biotech, Federal Drug Reimbursement Program, Law on Amendments to the Law on Circulation of Medicines, Marathon Group, National Plan for Development and Competition, Pharma 2020, Pharma IQ, Pharmaceuticals, Rostec, Russia, Russian Ministry of Trade

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Healthcare IPOs keep rolling along, and not just in the US. Will March come in like a lion, or a...
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
  • IPOs are back in business; well, unless and until there’s another government shutdown.
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress